NCT04610138View on ClinicalTrials.gov

Study of ZnAg Liquid Solution to Treat COVID-19 Symptomatic Participants

PHASE2CompletedINTERVENTIONAL

Enrollment

296

Participants

Timeline

Start Date

June 1, 2021

Primary Completion Date

May 28, 2022

Study Completion Date

October 20, 2022

Conditions

Covid19

Interventions

DRUG

CNM-ZnAg

ZnAg liquid solution

DRUG

Placebo

Water

Trial Locations (5)

89020-430

PROCAPE, Santo Amaro

20020-000

Projeto Praca Onze, Centro

20241-180

IBPClin, Glória

14.784-400

Casa de Saúde, Campinas

13.060-080

IPECC, São Paulo

Sponsors

Lead Sponsor

Clene Nanomedicine

Collaborators (1)

All Listed Sponsors

collaborator

ICL Pharma

UNKNOWN

collaborator

Azidus Brazil

UNKNOWN

lead

Clene Nanomedicine

INDUSTRY